111 related articles for article (PubMed ID: 15627038)
1. Lipoatrophy and mitochondrial DNA assays: see all, know all?
Brinkman K
AIDS; 2005 Jan; 19(1):91-2. PubMed ID: 15627038
[No Abstract] [Full Text] [Related]
2. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine.
McComsey GA; Paulsen DM; Lonergan JT; Hessenthaler SM; Hoppel CL; Williams VC; Fisher RL; Cherry CL; White-Owen C; Thompson KA; Ross ST; Hernandez JE; Ross LL
AIDS; 2005 Jan; 19(1):15-23. PubMed ID: 15627029
[TBL] [Abstract][Full Text] [Related]
3. Acquired and inherited lipodystrophies.
Walker UA
N Engl J Med; 2004 Jul; 351(1):103-4; author reply 103-4. PubMed ID: 15229318
[No Abstract] [Full Text] [Related]
4. Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy.
García-Benayas T; Blanco F; de la Cruz JJ; Soriano V; González-Lahoz J
AIDS; 2003 Apr; 17(6):921-4. PubMed ID: 12660543
[No Abstract] [Full Text] [Related]
5. [Long-term tolerance. Preventing lipoatrophy].
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():39. PubMed ID: 15011584
[No Abstract] [Full Text] [Related]
6. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection.
McComsey GA; Libutti DE; O'Riordan M; Shelton JM; Storer N; Ganz J; Jasper J; Harrill D; Gerschenson M
Antivir Ther; 2008; 13(5):715-22. PubMed ID: 18771055
[TBL] [Abstract][Full Text] [Related]
9. Stavudine in antiretroviral therapy: is this the end?
Brinkman K
AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
[No Abstract] [Full Text] [Related]
10. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
van der Valk M; Casula M; Weverlingz GJ; van Kuijk K; van Eck-Smit B; Hulsebosch HJ; Nieuwkerk P; van Eeden A; Brinkman K; Lange J; de Ronde A; Reiss P
Antivir Ther; 2004 Jun; 9(3):385-93. PubMed ID: 15259901
[TBL] [Abstract][Full Text] [Related]
11. Managing HIV lipoatrophy.
Moyle G; Sutinen J
Lancet; 2004 Feb; 363(9407):412-4. PubMed ID: 14962517
[No Abstract] [Full Text] [Related]
12. Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).
Ribera E; Paradiñeiro JC; Curran A; Sauleda S; García-Arumí E; Castella E; Puiggròs C; Crespo M; Feijoo M; Diaz M; Del Saz SV; Planas M; Sureda D; Falcó V; Ocaña I; Pahissa A
HIV Clin Trials; 2008; 9(6):407-17. PubMed ID: 19203906
[TBL] [Abstract][Full Text] [Related]
13. Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
Martin A; Smith DE; Carr A; Ringland C; Amin J; Emery S; Hoy J; Workman C; Doong N; Freund J; Cooper DA;
AIDS; 2004 Apr; 18(7):1029-36. PubMed ID: 15096806
[TBL] [Abstract][Full Text] [Related]
14. Changes in body fat measured by DEXA in patients taking different formulations of stavudine.
Yang Y; Wilder-Smith A; Panchalingam A; Tha NO; Paton NI
HIV Clin Trials; 2005; 6(6):337-43. PubMed ID: 16452067
[TBL] [Abstract][Full Text] [Related]
15. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
[TBL] [Abstract][Full Text] [Related]
16. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
Nolan D; Mallal S
J HIV Ther; 2004 May; 9(2):34-40. PubMed ID: 15238874
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy.
Moyle GJ; Sabin CA; Cartledge J; Johnson M; Wilkins E; Churchill D; Hay P; Fakoya A; Murphy M; Scullard G; Leen C; Reilly G;
AIDS; 2006 Oct; 20(16):2043-50. PubMed ID: 17053350
[TBL] [Abstract][Full Text] [Related]
18. No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
Calmy A; Bloch M; Wand H; Delhumeau C; Finlayson R; Rafferty M; Norris R; Hirschel B; Cooper DA; Carr A;
HIV Med; 2010 Sep; 11(8):493-501. PubMed ID: 20236365
[TBL] [Abstract][Full Text] [Related]
19. Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery.
Nasi M; Pinti M; Chiesa E; Fiore S; Manzini S; Del Giovane C; D'Amico R; Palai N; Campatelli C; Sabbatini F; Roccio M; Tibaldi C; Masuelli G; Mussini C; Ferrazzi E; d'Arminio Monforte A; Cossarizza A;
Antivir Ther; 2011; 16(3):365-72. PubMed ID: 21555819
[TBL] [Abstract][Full Text] [Related]
20. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside reverse transcriptase inhibitors.
Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM;
Antivir Ther; 2007; 12(2):205-16. PubMed ID: 17503663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
